Meatly, a UK cultivated meat company, has secured a £10.4 million Series A round to fund the construction of a 20,000-litre bioreactor facility in London. This facility is set to become the largest cultivated meat production site in Europe, with product releases expected in 2027. The funding round, which brings total funding raised to £17.4 million, was joined by three new institutional investors, including Oyster Bay Venture Capital, Clean Growth Fund, and JamJar Investments.

Pet food will be the commercial entry point for Meatly's production at the new facility, where the company already holds a unique position. With a focus on reducing production costs, Meatly has made significant progress in bringing down costs of growth medium and bioreactor technology. The investment is seen as a powerful endorsement of Meatly and Britain's foodtech and biotech sectors, as the company aims to make commercially viable cultivated meat a reality.